The Scientist

» immunotherapy and genetics & genomics

Most Recent

image: Criticism for Craig Venter’s “Face-Prediction” Software

Criticism for Craig Venter’s “Face-Prediction” Software

By | September 11, 2017

The tool cannot predict a person’s face from DNA, say researchers—including some listed as coauthors on the publication. 

1 Comment

image: Fingerprints of Ongoing Human Evolution Found

Fingerprints of Ongoing Human Evolution Found

By | September 5, 2017

Genetic variants in Alzheimer’s- and smoking-related genes appear to be under selection pressure, according to a study comparing the genomes of old and young participants.

1 Comment

Exposure to the body’s humidity causes a film of the microbes to change shape, opening flaps in the garment to allow for increased airflow.

4 Comments

image: Contributors

Contributors

By | September 1, 2017

Meet some of the people featured in the September 2017 issue of The Scientist.

0 Comments

image: CRISPR May Prove Useful in De-Extinction Efforts

CRISPR May Prove Useful in De-Extinction Efforts

By | September 1, 2017

Researchers are using the powerful gene-editing tool to recreate the woolly mammoth.

0 Comments

image: Infographic: The Various Forms of Methylated DNA

Infographic: The Various Forms of Methylated DNA

By | September 1, 2017

To expand the basic nucleotide alphabet, many species modify their DNA with epigenetic marks.

0 Comments

image: The Role of DNA Base Modifications

The Role of DNA Base Modifications

By | September 1, 2017

Researchers are just beginning to scratch the surface of how several newly recognized epigenetic changes function in the genome.

3 Comments

image: First CAR T-Cell Therapy Approved in U.S.

First CAR T-Cell Therapy Approved in U.S.

By | August 30, 2017

The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.

1 Comment

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

image: Global Patterns of Human Epigenetic Variation

Global Patterns of Human Epigenetic Variation

By | August 28, 2017

A study of five far-flung human populations gives clues to adaptations to environmental pressures.

5 Comments

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip